Close Menu

IBM

San Diego State University has received US Patent No. 8,268,551, "Sensitive sensing based on optical nonlinear wave mixing." The patent claims techniques for using four-wave mixing in microarrays with sample cells of biological or chemical materials.

Two supercomputers dedicated to life science research — both from Japan — have joined the ranks of the world's fastest supercomputers, according to the twice-yearly Top500 list released earlier this month.

As part of a restructuring of its Applied Science unit that includes shuttering its NimbleGen microarray business, Roche will integrate its 454 sequencing platforms and Roche NimbleGen sequence capture products more closely under a new business group called Sequencing Solutions.

By Uduak Grace Thomas
IBM and Memorial Sloan-Kettering Cancer Center are partnering to apply IBM's Watson artificial intelligence technology to cancer diagnosis and therapy selection.

By Uduak Grace Thomas
This report has been updated to include corrections to Silvana Canevari's position at the institute and to clarify comments from Michele Torresani

US Patent 8,131,473. Data analysis methods for locating entities of interest within large, multivariable datasets. Inventors: Marie Coffin, Keith Allen, Brian Bullard, Alan Higgins. Assignee: Metabolon

By Bernadette Toner
Tobacco giant Philip Morris International is partnering with IBM in an effort to advance the industrial applications of systems biology and computational modeling.

IBM has formed a healthcare advisory board for its Watson computing system that includes Lynda Chin as a member. Chin is a professor and chair of the department of genomic medicine at the University of Texas MD Anderson Cancer Center.

Pages

A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.

According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.

In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.